小分子作为3-甲基葡萄糖化替代基质
Elizabeth A Jennings1, Irina Romenskaia1, Robert O Ryan1
1Department of Biochemistry and Molecular Biology University of Nevada Reno Nevada USA.
JIMD reports
|October 17, 2025
概括
代谢的先天性错误可能会导致转-3-甲基谷 CoA 的有毒积累. 这项研究表明,含有初级氨基的分子可以与活性3MGC无水化物反应,防止蛋白质损伤.
科学领域:
- 生物化学 生物化学
- 代谢障碍 代谢障碍 代谢障碍
- 有机化学 有机化学
背景情况:
- 氨酸的催化产生了转-3-甲基谷 CoA (3MGC-CoA).
- 在HMGCL或AUH (代谢的先天性错误) 中的酶缺乏会提高3MGC-CoA水平.
- 升高的3MGC-CoA可以非酶性形成3MGC无水化物,导致有机酸废物和蛋白质3MGCylation.
研究的目的:
- 研究3MGC无水化物与小分子的反应性.
- 评估小分子减轻3MGC无水化物诱导的蛋白质修饰的潜力.
主要方法:
- 在体外实验中使用抗-3MGC抗体.
- 评估3MGCylated牛血清白蛋白 (BSA) 信号强度的降低.
- 测试各种小分子,包括含有氨基基团的化合物.
主要成果:
- 甘氨酸,葡萄糖胺,乙醇胺和谷氨以度依赖的方式降低了3MGCylated BSA信号强度.
- 这些反应性分子含有主要的氨基基团.
- N-乙葡萄糖胺和胆没有显示出显著的影响.
结论:
- 3MGC无水化物与含有主要氨酸的代谢产物发生反应.
- 这种反应会使这些代谢产物的主要氨基基团发生化.
- 在特定的IEM中管理有毒代谢物积累的潜在治疗策略.
相关概念视频
Drug Metabolism: Phase II Reactions
4.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.9K
Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
Oligosaccharide Assembly
3.5K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.5K
Sulfur Assimilation
318
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
318
Biosynthesis of Polysaccharides
548
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
548
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
817
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
817


